Endless manufacturing suspension and temporary out-of-stock of medicines

Published: 2017-06-12 10:23:40

Updated: 2017-06-12 10:23:40

Multinational pharmaceutical companies have decided to suspend supplying pharmaceutical products in Korea, and Korean pharmaceutical companies have temporarily gone out-of-stock on some of their products.

Novartis and Sanofi Pasteur informed domestic supply of some of their pharmaceutical products.

Followed by its headquarters’ decision, Novartis expected suspension of supply on Dynacirc SR C...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.